Inflammatory leukocytes associated with increased immunosuppression by glioblastoma
- PMID: 1318961
- DOI: 10.3171/jns.1992.77.1.0120
Inflammatory leukocytes associated with increased immunosuppression by glioblastoma
Abstract
In order to determine the in vivo immune response in glioblastoma, monoclonal and polyclonal antibodies specific for inflammatory leukocytes and immunoregulatory products were utilized to stain tissue from four surgical specimens. The more activated the inflammatory cells, the more activated the tumors appeared to be. In the tumor with the largest infiltration (Case 3), inflammatory cells were stained for interferon-gamma, interleukin-2, interleukin-1 beta, lymphotoxin, tumor necrosis factor-alpha, and transforming growth factor-beta. The tumor cells also expressed interleukin-1 beta, interleukin-6, transforming growth factor-beta, tumor necrosis factor-alpha, and prostaglandin E. In contrast, in the tumor with the least inflammatory response (Case 1), the tumor cells did not express any cytokines. Expression of cytokines by glioma cells was modest in the two cases with modest inflammatory responses. Cellular inflammation, primarily consisting of T cells and macrophages with few or no B cells or natural killer cells, was two- to 15-fold greater outside the tumor than within. In contrast to leukocytes outside the tumor, which were activated and expressing class II major histocompatibility antigens, leukocytes within the tumor parenchyma or at the tumor's edge were negative for these antigens. In the four specimens studied here, the tumor cells themselves were also negative for class II major histocompatibility antigens. These findings, although preliminary, suggest that inflammatory cells within gliomas are inactivated and that glioma cells may increase the expression of immunosuppressive cytokines in response to an increased lymphocyte infiltrate. This observation, if corroborated by more extensive studies, may help to explain the failure of immune treatments in glioblastoma multiforme.
Similar articles
-
Cytokines and immunoregulatory molecules in malignant glial neoplasms.J Neurosurg. 1992 Aug;77(2):265-73. doi: 10.3171/jns.1992.77.2.0265. J Neurosurg. 1992. PMID: 1625016
-
Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.Clin Cancer Res. 2005 Jul 15;11(14):5292-9. doi: 10.1158/1078-0432.CCR-05-0545. Clin Cancer Res. 2005. PMID: 16033848 Clinical Trial.
-
Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors.J Neurosurg. 1999 Dec;91(6):935-46. doi: 10.3171/jns.1999.91.6.0935. J Neurosurg. 1999. PMID: 10584838
-
The role of regulatory T-cells in glioma immunology.Clin Neurol Neurosurg. 2014 Apr;119:125-32. doi: 10.1016/j.clineuro.2013.12.004. Epub 2014 Jan 3. Clin Neurol Neurosurg. 2014. PMID: 24582432 Review.
-
Glioblastoma-derived mechanisms of systemic immunosuppression.Neurosurg Clin N Am. 2010 Jan;21(1):31-42. doi: 10.1016/j.nec.2009.08.005. Neurosurg Clin N Am. 2010. PMID: 19944964 Review.
Cited by
-
An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats.J Neurooncol. 2005 Aug;74(1):9-17. doi: 10.1007/s11060-004-3339-x. J Neurooncol. 2005. PMID: 16078102
-
Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.J Clin Invest. 1994 Sep;94(3):954-64. doi: 10.1172/JCI117462. J Clin Invest. 1994. PMID: 7521890 Free PMC article.
-
Cell adhesion molecules acting between C6 glioma and endothelial cells.J Neurooncol. 1995;24(2):181-8. doi: 10.1007/BF01078488. J Neurooncol. 1995. PMID: 7562005
-
Immunological Evasion in Glioblastoma.Biomed Res Int. 2016;2016:7487313. doi: 10.1155/2016/7487313. Epub 2016 May 15. Biomed Res Int. 2016. PMID: 27294132 Free PMC article. Review.
-
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.Curr Top Med Chem. 2005;5(12):1151-70. doi: 10.2174/156802605774370856. Curr Top Med Chem. 2005. PMID: 16248789 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical